Overview
Arthrogryposis, renal dysfunction, and cholestasis (ARC) syndrome is a rare genetic disorder characterized by joint contractures, renal impairment, and liver dysfunction, often linked to mutations in VPS33B, affecting platelet alpha-granule biogenesis and function 1.Diagnosis
Clinical Features: Joint contractures, renal dysfunction, cholestasis, and bleeding diathesis 1.
Laboratory Tests: Platelet aggregation studies showing reduced response to arachidonate and ADP 1.
Platelet Analysis: Increased platelet size, absence of alpha-granules, elevated delta-granules, and decreased releasable protein pools 1.
Genetic Testing: Identification of VPS33B mutations 1.Management
Bleeding Management: Monitor and manage bleeding episodes with supportive care; specific pharmacological interventions not detailed in current abstracts 1.
Renal Support: Regular monitoring and management of renal function, including dialysis if necessary 1.
Hepatic Care: Surveillance for liver complications and management of cholestasis with appropriate medical interventions 1.Special Populations
Pediatrics: Early intervention for joint contractures and developmental support crucial 1.
Comorbidities: Close monitoring of renal and hepatic functions in patients with additional comorbidities 1.Key Recommendations
Genetic Testing for VPS33B Mutations: Essential for confirming diagnosis in suspected cases (Evidence: Moderate 1).
Regular Monitoring of Platelet Function: Including aggregation studies to manage bleeding risks (Evidence: Moderate 1).
Comprehensive Multidisciplinary Care: Addressing renal, hepatic, and musculoskeletal aspects is critical for patient management (Evidence: Expert opinion 1).References
1 Lo B, Li L, Gissen P, Christensen H, McKiernan PJ, Ye C et al.. Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet alpha-granule biogenesis. Blood 2005. link